EVOXAC

This brand name is authorized in Japan, United States

Active ingredients

The drug EVOXAC contains one active pharmaceutical ingredient (API):

1 Cevimeline UNII P81Q6V85NP - CEVIMELINE HYDROCHLORIDE

Cevimeline is a cholinergic agonist which binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands and increase tone of the smooth muscle in the gastrointestinal and urinary tracts. Read about Cevimeline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EVOXAC Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07AX03		N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AX Other parasympathomimetics
Discover more medicines within N07AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 2399012M1026
Country: US	FDA, National Drug Code	Identifier(s): 63395-201